[Inhibition of the blastomogenic effect of 7,12-dimethylbenz(a)anthracene in female rats by buformin, diphenin, a polypeptide pineal extract and L-DOPA]

Biull Eksp Biol Med. 1980 Jun;89(6):723-5.
[Article in Russian]

Abstract

Female rats were treated with buformin, phenytoin, polypeptide pineal extract, L-DOPA or buformin combined with L-DOPA during 3 weeks before intravenous injections of DMBA (1.5 mg 6 times with one-week intervals) over a period of carcinogen injections and after it till the animals' death. The overall tumour incidence in the control group was 97%, while in buformin, phenytoin, pineal extract, L-DOPA and buformin + L-DOPA treated groups it amounted to 55, 71, 80, 50 and 62%, respectively (P < 0.05). The incidence of mammary adenocarcinoma amounted to 81, 36, 55, 26, 25 and 19%, respectively (P < 0.05). The mechanisms of the similar effects the drugs belonging to different classes produce on chemical carcinogenesis are discussed.

Publication types

  • English Abstract

MeSH terms

  • 9,10-Dimethyl-1,2-benzanthracene / antagonists & inhibitors*
  • Adenocarcinoma / prevention & control*
  • Adenofibroma / prevention & control
  • Animals
  • Antineoplastic Agents*
  • Benz(a)Anthracenes / antagonists & inhibitors*
  • Buformin / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Fibroma / prevention & control
  • Levodopa / therapeutic use
  • Mammary Neoplasms, Experimental / prevention & control*
  • Peptides / isolation & purification
  • Peptides / therapeutic use
  • Phenytoin / therapeutic use
  • Pineal Gland / analysis
  • Rats

Substances

  • Antineoplastic Agents
  • Benz(a)Anthracenes
  • Peptides
  • Levodopa
  • 9,10-Dimethyl-1,2-benzanthracene
  • Phenytoin
  • Buformin